Yoga for Adolescent and Young Adult Non-Curative Cancer Patients
|ClinicalTrials.gov Identifier: NCT01901237|
Recruitment Status : Completed
First Posted : July 17, 2013
Last Update Posted : July 13, 2017
|Condition or disease||Intervention/treatment|
|Advanced Cancer||Behavioral: Hatha Yoga|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||5 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Impact of Yoga on Quality of Life for Adolescent and Young Adult Non-Curative Cancer Patients: A Pilot Study|
|Study Start Date :||September 2013|
|Primary Completion Date :||June 13, 2017|
|Study Completion Date :||June 13, 2017|
Hatha Yoga Program
Single-arm pilot study of a 7-week home/hospice-based Hatha yoga program for adolescent and young adults with non-curative cancer.
Behavioral: Hatha Yoga
This is a 7-week home/hospice-based instructive Hatha yoga program (available on DVD) for adolescent and young adults diagnosed with a non-curative cancer. Participants will be asked to complete a minimum of one, 75-minute yoga session per week. The DVD package includes four discs that increase in difficulty over the course of the 7-week program. The DVD focuses on postures and breathing exercises. Participants will be asked to keep track of the number and duration of yoga sessions completed over the 7-week period.
- Feasibility: Recruitment [ Time Frame: Final: end of week 7 ]Recruitment will be calculated by the number of patients who consent to participate, divided by the number of eligible participants recommended by the primary oncologist/physician.
- Feasibility: Retention [ Time Frame: Final: end of week 7 ]Retention: Will be determined by reporting the number of participants who complete the baseline and post-program questionnaire and follow-up testing.
- Feasibility: Adherence [ Time Frame: Final: end of week 7 ]Adherence: Participants will be asked to record the number of yoga sessions performed each week. Overall adherence will be calculated by summing the actual number of sessions the participant engaged in, divided by the recommended number of sessions.
- Safety [ Time Frame: Final: end of week 7 ]Safety: Any adverse events reported by the participant will be recorded.
- Changes in Quality of Life [ Time Frame: Baseline: week 1; Final: week 7 ]Participants will be asked to complete the Functional Assessment of Chronic Illness Therapy - Palliative Care subscale (FACIT-Pal) and the Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being subscale (FACIT-Sp) at baseline and post-intervention.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01901237
|Canada, Nova Scotia|
|Halifax, Nova Scotia, Canada, B3H 4R2|
|Principal Investigator:||Rob Rutledge, MD, FRCPC||Capital District Health Authority, Halifax, Canada|